Ill. Admin. Code tit. 35, § 726.607 - Residues in Empty Containers
a) Stock,
Dispensing and Unit-Dose Containers. A stock bottle, dispensing bottle, vial,
or ampule (not to exceed 1 liter or 10,000 pills); or a unit-dose container
(e.g., a unit-dose packet, cup, wrapper, blister pack, delivery device, etc.)
is considered empty and the residues are not regulated as hazardous waste,
provided the pharmaceuticals have been removed from the stock bottle,
dispensing bottle, vial, ampule, or unit-dose container using the practices
commonly employed to remove materials from that type of container.
b) Syringes. A syringe is considered empty
and the residues are not regulated as hazardous waste under this Subpart P,
provided the contents have been removed by fully depressing the plunger of the
syringe. If a syringe is not empty, the syringe must be placed with its
remaining hazardous waste pharmaceuticals into a container that is managed and
disposed of as a non-creditable hazardous waste pharmaceutical under this
Subpart P and any applicable federal, State, and local requirements for sharps
containers and medical waste.
c)
Intravenous (IV) Bags. An IV bag is considered empty and the residues are not
regulated as hazardous waste, provided the pharmaceuticals in the IV bag have
been fully administered to a patient. If an IV bag is not empty, the IV bag
must be placed with its remaining hazardous waste pharmaceuticals into a
container that is managed and disposed of as a non-creditable hazardous waste
pharmaceutical under this Subpart P, unless the IV bag held non-acute hazardous
waste pharmaceuticals and is empty, as defined in 35 Ill. Adm. Code
721.107(b)(1).
d) Other Containers, Including Delivery
Devices. Hazardous waste pharmaceuticals remaining in all other types of
unused, partially administered, or fully administered containers must be
managed as non-creditable hazardous waste pharmaceuticals under this Subpart P,
unless the container held nonacute hazardous waste pharmaceuticals and is
empty, as defined in 35 Ill. Adm. Code
721.107(b)(1)
or (b)(2). This includes residues in
inhalers, aerosol cans, nebulizers, tubes of ointments, gels, or
creams.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.